ERDERA
@erdera.bsky.social
210 followers
75 following
120 posts
Advancing prevention, diagnosis and treatment research for the 30 million people living with a rare disease in Europe.
🔗 erdera.org
Co-funded by European Union's #HorizonEU Research & Innovation programme. Views expressed are of authors only.
Posts
Media
Videos
Starter Packs
ERDERA
@erdera.bsky.social
· 17h
Networking Support Scheme - ERDERA
ERDERA's Networking Support Scheme helps promote knowledge sharing on rare diseases and rare cancers through the funding of events. It also encourages the participation from underrepresented European countries in networks.
erdera.org
ERDERA
@erdera.bsky.social
· 29d
Shaping the future of global rare disease research: Join the 2nd International Conference on Clinical Research Networks - ERDERA
ERDERA is pleased to announce the upcoming 2nd International Conference on Clinical Research Networks (CRNs) for Rare Diseases, co-organised in collaboration with Rare Disease International and the International Rare Diseases Research Consortium (IRDiRC).
erdera.org
ERDERA
@erdera.bsky.social
· Sep 7
Open Academy Schools 2026: applications open 8 September 2025 - ERDERA
From 25–28 May 2026, Barcelona will host the next EURORDIS Open Academy Schools. Applications for the Medicines Research & Development School and the Scientific Innovation & Translation School open on 8 September 2025. Subscribe to the Open Academy and EURORDIS newsletters to receive the link as soon as the call goes live. What awaits in
erdera.org
ERDERA
@erdera.bsky.social
· Aug 4
Open Academy Schools 2026: applications open 8 September 2025 - ERDERA
From 25–28 May 2026, Barcelona will host the next EURORDIS Open Academy Schools. Applications for the Medicines Research & Development School and the Scientific Innovation & Translation School open on 8 September 2025. Subscribe to the Open Academy and EURORDIS newsletters to receive the link as soon as the call goes live. What awaits in
erdera.org
ERDERA
@erdera.bsky.social
· Jul 30
CRISPR-Cas: From biology to therapeutic applications
A decade of groundbreaking research on bacterial CRISPR-Cas defence systems has culminated in the development of revolutionary editing technologies. This tool has been exploited to create transgenic …
meetings.embo.org